Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The degree of crystallinity or amorphism in pharmaceutical materials is recognized as a critical factor that may affect drug stability and dosage form performance. Consequently, it is important to monitor the extent of crystallinity during bulk material scale‐up, formulation development, manufacturing, and over the intended shelf‐life of a pharmaceutical product.